No increase in demand for COVID-19 vaccines from visitors, private patients: MOH

日本 ニュース ニュース

No increase in demand for COVID-19 vaccines from visitors, private patients: MOH
日本 最新ニュース,日本 見出し
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 66%

The ministry's comments come amid concerns about a potential surge in demand for COVID-19 vaccines from tourists following China's reopening.

Amid concerns about the demand and supply of COVID-19 vaccines in Singapore, the Health Ministry said it has sufficient stock available for Singaporeans and residents under its national vaccination programme.

“Our supply contracts provide us with the flexibility to procure more vaccines if necessary. There is therefore sufficient stock available for Singaporeans and residents under the national vaccination programme." Under the private programme, seven clinics are approved to offer COVID-19 vaccines - including the Moderna and Pfizer bivalent shots - to people aged 12 and above.Healthway Medical told CNA that it has seen an increase in demand for the vaccines, adding that it increased booking capacity by 50 per cent in response.

Checks by CNA showed that the price per dose ranges from S$140.40 to S$150 at clinics that offer the Moderna bivalent vaccine, while clinics offering the Pfizer bivalent vaccine listed a price of S$188 per dose.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

ChannelNewsAsia /  🏆 6. in SG

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

China-Myanmar border towns eye revival after COVID-19 traumaChina-Myanmar border towns eye revival after COVID-19 traumaRUILI, China: At a checkpoint on China's southern frontier with Myanmar, shuttered stores advertising the region's famed jade jewellery appear abandoned, driven out of business by a pandemic-induced closure of the border. The city of Ruili is slowly creaking back to life as China ditches its zero-tolerance
続きを読む »

China braces for Covid-19 holiday surge as people leave megacities for hometownsChina braces for Covid-19 holiday surge as people leave megacities for hometownsChina’s transport ministry said it expects more than 2 billion trips in the weeks around the holidays. Read more at straitstimes.com.
続きを読む »

In China, no easy way to get Pfizer's Covid-19 drug PaxlovidIn China, no easy way to get Pfizer's Covid-19 drug PaxlovidSome people have turned to the grey market to purchase Paxlovid. Read more at straitstimes.com.
続きを読む »

China braces for COVID-19 holiday surge as people leave megacities for hometownsChina braces for COVID-19 holiday surge as people leave megacities for hometownsBEIJING: Luggage-laden passengers flocked to railway stations and airports in China's megacities on Monday (Jan 16), heading home for holidays that health experts fear could intensify a COVID-19 outbreak that has claimed thousands of lives. After three years of strict and suffocating anti-virus controls,
続きを読む »

China braces for COVID-19 holiday surge as people leave megacities for hometownsChina braces for COVID-19 holiday surge as people leave megacities for hometownsBEIJING: Luggage-laden passengers flocked to railway stations and airports in China's megacities on Monday (Jan 16), heading home for holidays that health experts fear could intensify a COVID-19 outbreak that has claimed thousands of lives. After three years of strict and suffocating anti-virus controls,
続きを読む »

China to boost spending for Covid-19 prevention, treatmentChina to boost spending for Covid-19 prevention, treatmentLocal fiscal departments urged to step up transfer payments to rural and poor areas. Read more at straitstimes.com.
続きを読む »



Render Time: 2025-04-03 12:47:45